NEURODERM

Serial Number 79299574
Registration 6358631
700

Registration Progress

Application Filed
May 4, 2020
Under Examination
Approved for Publication
Mar 9, 2021
Published for Opposition
Mar 9, 2021
Registered
May 25, 2021

Trademark Image

NEURODERM

Basic Information

Serial Number
79299574
Registration Number
6358631
Filing Date
May 4, 2020
Registration Date
May 25, 2021
Published for Opposition
March 9, 2021
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
May 25, 2021
Registration
Registered
Classes
005 010

Rights Holder

Neuroderm LTD

16
Address
3 Pekeris Street
7670212 Rehovot
IL

Ownership History

Neuroderm LTD

Original Applicant
16
IL

Neuroderm LTD

Owner at Publication
16
IL

Neuroderm LTD

Original Registrant
16
IL

Legal Representation

Attorney
A. Tally Eitan

USPTO Deadlines

Next Deadline
663 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-05-25)
Due Date
May 25, 2027
Grace Period Ends
November 25, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

39 events
Date Code Type Description Documents
Jul 30, 2022 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Jun 9, 2022 INNA R INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Loading...
Feb 9, 2022 INPR P PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Loading...
Oct 4, 2021 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Sep 11, 2021 FIMP P FINAL DISPOSITION PROCESSED Loading...
Sep 11, 2021 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Aug 25, 2021 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jun 10, 2021 LIME I LIMITATION FROM THE IB EXAMINED AND ENTERED Loading...
Jun 9, 2021 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jun 9, 2021 COC. O CORRECTION UNDER SECTION 7 - PROCESSED Loading...
Jun 9, 2021 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
May 25, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 23, 2021 LIMG M LIMITATION OF GOODS RECEIVED FROM IB Loading...
Mar 22, 2021 LIMN I LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED Loading...
Mar 15, 2021 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Mar 9, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 9, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 28, 2021 LIMG M LIMITATION OF GOODS RECEIVED FROM IB Loading...
Feb 24, 2021 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Feb 24, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Feb 17, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 2, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 2, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Feb 2, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 2, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 2, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 2, 2021 ALIE A ASSIGNED TO LIE Loading...
Feb 1, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 1, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 1, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 24, 2021 RFNT P REFUSAL PROCESSED BY IB Loading...
Dec 30, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Dec 29, 2020 RFRR P REFUSAL PROCESSED BY MPU Loading...
Dec 15, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Dec 15, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Dec 14, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 11, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 11, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 10, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceuticals, namely, pharmaceutical preparations for use in preventing and treating conditions, diseases, or disorders of the central nervous, neurological, cardiovascular, endocrine, gastric or gastroenteric, hematologic, immunologic, inflammatory, osteologic, or respiratory systems; pharmaceutical preparations for use in prevention and treatment of allergies or allergic responses, metabolic disorders, psychiatric and emotional disorders, infection and infectious diseases, pain; drug delivery kits comprising dressings for medical, surgical, and veterinary use [ ; drug delivery agents, namely, transdermal patches sold with medication for use in the treatment of conditions, diseases or disorders of the central nervous, neurological, cardiovascular, endocrine, gastric or gastroenteric, hematologic, immunologic, inflammatory, osteologic, or respiratory systems ]
First Use Anywhere: 0
First Use in Commerce: 0
Class 010
Medical devices for delivery of medicated and pharmaceutical preparations, namely, implantable drug delivery pumps, drug delivery catheters, drug delivery patches sold without medication, subcutaneous drug delivery pumps, subcutaneous drug delivery patch pumps, refillable drug delivery pumps, and infusion drug delivery pumps; drug delivery device sold empty, namely, syringes, infusion drug delivery pumps; infusion sets; electromagnetic drug delivery apparatus for medical use; medical apparatus, namely, implantable ports; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and medical instruments for administering fluid, drugs, and nutrition, namely, infusion pumps, patch pumps being adherable subcutaneous drug delivery pumps, wearable medication injectors, wearable subcutaneous drug delivery pumps, and handheld medication injectors; medical syringes; medical devices in the nature of infusion pumps for drug infusion and for monitoring the infusion of drugs with integrated recorded software for transmission and receiving of drug infusion data, data related to the infusion pumps, drug infusion monitoring, filling and emptying of drug vials, and patient's behavior and reaction to drugs, sold as a unit therewith; drug delivery devices, namely, catheters, injection pen needles, injection needles, injection syringes and implantable subcutaneous drug delivery pumps; lancets; medical lancing devices for delivering medication, sold empty; drug eluting stents; bio-absorbable stents; synthetic stent grafts; medical diagnostic apparatus used to detect and measure the level of substances in body fluids; medical apparatus for measuring dosages and delivering pharmaceuticals, namely, infusion drug delivery pumps, subcutaneous drug delivery wearable pumps, subcutaneous drug delivery patch pumps, implantable drug delivery pumps and injection pens; electromedical rehabilitative and pain management products for clinical and home use, namely, electrical nerve and muscle stimulators, ultrasonic stimulators, magnet therapy stimulators and laser therapy stimulators; electronickinetic transdermal drug delivery control unit for the treatment of diseases
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Other
In the statement, " International Class 5 " is corrected per the restriction and the fnote dated 5/25/2021

Classification

International Classes
005 010